Topic: Health

Researchers at UCLA discovered a hidden weakness in some aggressive cancers. They found that these cancer cells rely on a protein called E2F3 to survive, and blocking it can stop tumor growth. This breakthrough could lead to new treatments.

Scientists at the University of California, Los Angeles (UCLA) have made an exciting discovery about certain types of cancer. These cancers, known as small cell neuroendocrine cancers, are very aggressive and hard to treat.

They can develop in different parts of the body, such as the lung, prostate, and ovary. What makes them so difficult to treat is that they often lose a gene called RB, which helps control cell growth. When this gene is missing, cancer cells multiply quickly and become resistant to many treatments.

The UCLA team used laboratory experiments to study these cancers. They created models of small cell prostate cancer in mice by engineering normal human prostate cells with genetic changes, including the loss of RB. These models closely resemble human tumors.

The researchers then performed a type of test called CRISPR screens on thousands of genes to see which ones were essential for cancer cell survival. They found that nearly 1,400 genes play important roles in keeping these cancer cells alive.

One of the most significant discoveries was that small cell cancers from different organs all share a strong dependence on E2F3. When they blocked E2F3, the tumors stopped growing and even died in some cases.

Why It Matters

This breakthrough is important because it could lead to new treatments for deadly cancers that have been resistant to current therapies. With this knowledge, scientists can develop targeted therapies that attack these cancer cells more effectively.

Key Facts

• Small cell neuroendocrine cancers are aggressive and hard to treat, developing in the lung, prostate, and ovary.
• These cancers often lose a gene called RB, which helps control cell growth.
• The UCLA team created models of small cell prostate cancer in mice by engineering normal human prostate cells with genetic changes.
• CRISPR screens revealed that nearly 1,400 genes play important roles in keeping these cancer cells alive.
• Small cell cancers from different organs share a strong dependence on E2F3.

Key Terms

RB

A gene that helps control cell growth

E2F3

A protein that cancer cells rely on to survive

Implications

This breakthrough is important because it could lead to new treatments for deadly cancers that have been resistant to current therapies. With this knowledge, scientists can develop targeted therapies that attack these cancer cells more effectively.